» Articles » PMID: 22879996

Perfluorinated Compounds in Umbilical Cord Blood and Adverse Birth Outcomes

Overview
Journal PLoS One
Date 2012 Aug 11
PMID 22879996
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous animal studies have shown that perfluorinated compounds (PFCs) have adverse impacts on birth outcomes, but the results have been inconclusive in humans. We investigated associations between prenatal exposure to perfluorooctanoic acid (PFOA), perfluorooctyl sulfonate (PFOS), perfluorononanoic acid (PFNA), and perfluoroundecanoic acid (PFUA) and birth outcomes.

Methods: In total, 429 mother-infant pairs were recruited from the Taiwan Birth Panel Study (TBPS). Demographic data were obtained by interviewing mothers using a structured questionnaire and birth outcomes were extracted from medical records. Cord blood was collected for PFOA, PFOS, PFNA, and PFUA analysis by ultra-high-performance liquid chromatography/tandem mass spectrometry.

Results: The geometric mean (standard deviation) levels of PFOA, PFOS, PFNA, and PFUA in cord blood plasma were 1.84 (2.23), 5.94 (1.95), 2.36(4.74), and 10.26 (3.07) ng/mL, respectively. Only PFOS levels were found to be inversely associated with gestational age, birth weight, and head circumference [per ln unit: adjusted β (95% confidence interval, CI) = -0.37 (-0.60, -0.13) wks, -110.2 (-176.0, -44.5) gm and -0.25 (-0.46, -0.05) cm]. Additionally, the odds ratio of preterm birth, low birth weight, and small for gestational age increased with PFOS exposure [per ln unit: adjusted odds ratio (OR) (95%CI) = 2.45 (1.47, 4.08), 2.61(0.85, 8.03) and 2.27 (1.25, 4.15)]. When PFOS levels were divided into quartiles, a dose-response relation was observed. However, PFOA, PFNA, and PFUA were not observed to have any convincing impact on birth outcomes.

Conclusions: An adverse dose-dependent association was observed between prenatal PFOS exposure and birth outcomes. However, no associations were found for the other examined PFCs.

Citing Articles

Prenatal Perfluoroalkyl Substance Exposure in Association with Global Histone Post-Translational Methylation in 2-Year-Old Children.

Tsai W, Hsieh W, Chen P, Liu C Toxics. 2025; 12(12.

PMID: 39771091 PMC: 11679469. DOI: 10.3390/toxics12120876.


The Effects of Perfluorooctanesulfonic acid (PFOS) on Human Umbilical Vein Endothelial Cells (HUVECs) Proliferation and Gene Expression and its Implications on Fetal Development.

Ashby A, Murphy P, Jukosky J, Whipple C MicroPubl Biol. 2024; 2024.

PMID: 39712934 PMC: 11659881. DOI: 10.17912/micropub.biology.001318.


Per- and Polyfluoroalkyl Substances (PFAS) Affect Female Reproductive Health: Epidemiological Evidence and Underlying Mechanisms.

Qu R, Wang J, Li X, Zhang Y, Yin T, Yang P Toxics. 2024; 12(9).

PMID: 39330606 PMC: 11435644. DOI: 10.3390/toxics12090678.


Per- and polyfluoroalkyl substances (PFAS) and hypertensive disorders of Pregnancy- integration of epidemiological and mechanistic evidence.

Dangudubiyyam S, Hofmann A, Yadav P, Kumar S Reprod Toxicol. 2024; 130:108702.

PMID: 39222887 PMC: 11625001. DOI: 10.1016/j.reprotox.2024.108702.


Interaction of Per- and Polyfluoroalkyl Substances with Estrogen Receptors in Rainbow Trout (): An Investigation.

Bali S, Hall K, Massoud R, Almeida N, Wilson A Environ Sci Technol. 2024; 58(36):15960-15970.

PMID: 39207093 PMC: 11394024. DOI: 10.1021/acs.est.4c03648.


References
1.
Luebker D, York R, Hansen K, Moore J, Butenhoff J . Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology. 2005; 215(1-2):149-69. DOI: 10.1016/j.tox.2005.07.019. View

2.
Grasty R, Wolf D, Grey B, Lau C, Rogers J . Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B Dev Reprod Toxicol. 2004; 68(6):465-71. DOI: 10.1002/bdrb.10046. View

3.
Apelberg B, Goldman L, Calafat A, Herbstman J, Kuklenyik Z, Heidler J . Determinants of fetal exposure to polyfluoroalkyl compounds in Baltimore, Maryland. Environ Sci Technol. 2007; 41(11):3891-7. DOI: 10.1021/es0700911. View

4.
Abbott B, Wolf C, Das K, Zehr R, Schmid J, Lindstrom A . Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse. Reprod Toxicol. 2008; 27(3-4):258-265. DOI: 10.1016/j.reprotox.2008.05.061. View

5.
Wolf C, Zehr R, Schmid J, Lau C, Abbott B . Developmental effects of perfluorononanoic Acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha. PPAR Res. 2010; 2010. PMC: 2948904. DOI: 10.1155/2010/282896. View